Kantonsspital St.Gallen


Claudia Krieger Grübel

abstract Randomized, double-blind, double-dummy, placebo-controlled, Phase III
clinical trial on the efficacy and safety of a 12-weeks add-on treatment with
LT-02 (gastro-resistant phosphatidylcholine granules) vs. placebo in
patients with ulcerative colitis refractory to standard treatment with
type of project clinical studies
status aborted
start of project 2016
end of project 2017
responsible person Prof. Stephan Brand